Merck & Co., Inc.
Merck & Co. is a global pharmaceutical company with a dominant political signal being $21.0M in annual doctor payments and direct stock holdings by the executive branch.
BusinessWhat MRK does
Merck & Co. is a research-intensive biopharmaceutical company that discovers, develops, manufactures, and markets a broad range of human health products, including vaccines and oncology therapeutics. Its revenue is primarily derived from prescription medicines and vaccines sold globally.
12 months past · 3 months futureMRK activity timeline
Executive Branch ConflictsMRK held by Trump-administration officials
Lifetime Government AwardsMRK federal contracts
MRK doesn't hold direct federal contracts.
Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.
Smart Money · 13F HoldingsHedge funds holding MRK
Politicians Trading MRKMembers of Congress with recent MRK positions
Congressional TradesWho in Congress is trading MRK
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
Stock awards & option exercises
Bills Affecting MRKLive legislation impacting this stock
Political ProfileWhere MRK sits in Washington
[object Object]
STRUCTURAL: Strong committee alignment via donations to health subcommittee members ($21.6K total) and executive branch stock holdings (`get_executive_branch_exposure.by_ticker[0].holdings`). EVIDENTIARY: No recent corporate insider buys (Tier F, `get_corporate_insider_signal.total_buys` = 0) and net selling by congressional traders (7 sales vs. 4 purchases in last 12 months). Net: Structural access countered by weak transactional signals.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
Heightened scrutiny of physician payment relationships under transparency laws.HHS/CMS"`get_political_influence.doctor_payments` shows $21.0M in payments to 216,585 physicians in 2024."
Regulatory opportunities
-
Potential for defense-related chemical manufacturing contracts.DOD"Lobbying filing for 'MERCK KGAA' cites 'defense' issue area for 'chemical manufacturing' (`get_political_influence.lobbying.issue_areas`)."
Capitol Hill AlliesChampions & critics
Congressional champions
Congressional critics
- No specific congressional critics identified.
LobbyingWho's hired to advocate for MRK
Live signals + predictions for MRK — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades MRK
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord